Innovative drug concept stocks experienced a broad rally in early trading, with multiple leading companies posting significant gains. As of the latest update, Keymed Bio-B (02162) jumped 9.09% to HK$78.60, while Akeso (09926) advanced 8.90% to HK$98.55, both exceeding the 9% mark at their intraday highs.
Other notable performers in the sector also showed strong upward momentum, reflecting heightened investor optimism toward the biopharmaceutical industry. InnoCare Pharma (09969) rose 5.91% to HK$15.58, while Innovent Biologics (01801) gained 6.21% to HK$102.60, underscoring the widespread strength across innovative drug developers.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments